| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |